ArticleJournal of thrombosis and haemostasis : JTH2020
Specific coagulation markers may provide more therapeutic targets in COVID-19 patients receiving prophylactic anticoagulant.
Article in Journal of thrombosis and haemostasis : JTH, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04623177 (Effectiveness of Thromboprophylaxis With Low Molecular Weight Heparin in Critically Ill Patients With COVID-19. A Prospective, Cohort, Multicenter Study.), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effectiveness of Thromboprophylaxis With Low Molecular Weight Heparin in Critically Ill Patients With COVID-19. A Prospective, Cohort, Multicenter Study.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.
- Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data.Journal of neurology · 2021Pooled it
- A performance evaluation of chemiluminescence enzyme immunoassays on the Sysmex CN-6500 haemostasis analyser.International journal of laboratory hematology · 2021Article
- SELP Asp603Asn and severe thrombosis in COVID-19 males.Journal of hematology & oncology · 2021Article
- Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?Experimental gerontology · 2021Review
- Anticoagulant treatment in COVID-19: a narrative review.Journal of thrombosis and thrombolysis · 2021Review
- Anticoagulant treatment in COVID-19: a narrative review.Journal of thrombosis and thrombolysis · 2021Review
- Clinical Management of Hypertension, Inflammation and Thrombosis in Hospitalized COVID-19 Patients: Impact on Survival and Concerns.Journal of clinical medicine · 2021Article
- Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19.Blood advances · 2021Article
- Resolution of Disseminated Intravascular Coagulation in a Patient with COVID-19 and Associated Sepsis-Induced Neutropenia.Medicina (Kaunas, Lithuania) · 2021Article
- Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?Journal of thrombosis and thrombolysis · 2021Article
- The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects.Mediterranean journal of hematology and infectious diseases · 2021Review
- Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19.Journal of thrombosis and thrombolysis · 2020Review
- Fibrinolysis and COVID-19: A tale of two sites?Journal of thrombosis and haemostasis : JTH · 2020Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.